Related Experiment Videos
Improving body composition and physical activity in Prader-Willi Syndrome
Urs Eiholzer1, Yves Nordmann, Dagmar l'Allemand
1Foundation Growth Puberty Adolescence Zurich, Prevmedic, Bethanien Private Clinic, Zurich, Switzerland.
The Journal of Pediatrics
|January 10, 2003
Summary
Muscle training in Prader-Willi Syndrome (PWS) significantly improved body composition and increased physical activity and capacity. This easy-to-implement program offers a new therapeutic approach for PWS patients.
Area of Science:
- Pediatrics
- Genetics
- Exercise Physiology
Background:
- Prader-Willi Syndrome (PWS) is a complex genetic disorder.
- Individuals with PWS often experience challenges with body composition, physical capacity, and activity levels.
- Limited therapeutic options exist to address these physical impairments.
Purpose of the Study:
- To investigate the efficacy of a calf muscle training program in improving local body composition.
- To assess the impact of the training program on physical capacity and spontaneous physical activity in children and adolescents with PWS.
Main Methods:
- A 3-month daily calf muscle training program was conducted in 17 children/adolescents with PWS and 18 controls.
- Measurements included calf circumference, skinfold thickness, spontaneous physical activity (pedometer), and exercise capacity.
- Assessments were performed before training, at 3 months, and 3 months post-training.
Main Results:
- Calf skinfold thickness decreased and calf circumference increased in the PWS group, indicating improved muscle mass.
- Spontaneous physical activity significantly increased from 45% to 71% in the PWS group.
- Physical capacity showed a significant improvement, rising from 31% to 78% in the PWS group.
Conclusions:
- A structured calf muscle training program is effective in improving local body composition in individuals with PWS.
- The training program demonstrated generalized positive effects on physical activity and capacity.
- This intervention presents a promising new therapeutic strategy for managing metabolic conditions associated with PWS.